Livio Pellizzoni

14PUBLICATIONS
34CO-AUTHORS
Neurology and neuromuscular diseasesGenomics and transcriptomicsGene and molecular therapyOpen accessProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 03, 2026
A p53-ΔNp73 signaling axis drives selective motor neuron degeneration in spinal muscular atrophy.

|Feb 16, 2026
Nusinersen rescues taurine deficiency in patients with type 1 Spinal Muscular Atrophy.

Raffaella di Vito, Amber Hassan, Tommaso Nuzzo

|Sep 09, 2025
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy.

Maria J Carlini, Jorge Espinoza-Derout, Meaghan Van Alstyne

|Sep 05, 2025
Synaptic imbalance and increased inhibition impair motor function in SMA.

Emily V Fletcher, Joshua I Chalif, Travis M Rotterman

|Jun 30, 2025
Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophy.

Florian Gerstner, Sandra Wittig, Christian Menedo

|Apr 16, 2025
A chemical screen identifies p38 MAPK inhibition as a candidate neuroprotective strategy for combinatorial SMA therapy.

Maria J Carlini, Jorge Espinoza-Derout, Meaghan Van Alstyne

Pageof 3

Frequent Collaborators

3 joint publications

Christopher R Sibley

3 joint publications

Nicholas M Luscombe

3 joint publications

Christopher W J Smith

3 joint publications

Tomaž Curk